Vestibular Schwannoma Diagnosis
Vestibular Schwannoma Diagnosis
The diagnosis is made from the scan. A dedicated MRI with contrast, using thin slices through the internal auditory canal, shows a vestibular schwannoma directly, and the appearance is characteristic enough that no biopsy is needed at any point. The hearing tests travel with it: they do not make the diagnosis, but they record what the affected ear can still do, and that finding is one of the three things on which the whole plan rests.
Imaging: the scan that makes the diagnosis
Contrast-enhanced MRI with thin slices through the internal auditory canal is the diagnostic standard, and it answers the questions the plan depends on:
- Whether the tumour is there and where it sits — a vestibular schwannoma enhances brightly with contrast and is seen even when it is contained entirely within the canal. This is the point of the thin-slice protocol: a routine brain study with thicker slices can miss exactly these tumours, and a patient whose first scan was reported normal should know whether the internal auditory canals were covered.
- Its relationship to the structures that matter — how far it extends out of the canal, whether it touches the brainstem, and where the facial nerve is likely to run across its surface. These are the findings that decide what radiation can reach and what an operation can protect.
- What it is growing from — the appearance distinguishes a schwannoma of the hearing nerve from the other tumours that occur in this corner of the skull, which matters because their treatment differs.
- Whether the fluid spaces are still open — a very large tumour can obstruct the circulation of fluid around the brain, a finding that changes how urgent treatment is.
- Why the earlier scans matter — the diagnosis is made by one scan, but the decision is made by two. Growth is a comparison, and the comparison can only be made on the images themselves.
No biopsy is needed. Tissue is examined only in the uncommon event that the tumour is removed as treatment, and it confirms what the scan already showed. A patient who is asked to consider a needle biopsy for a typical vestibular schwannoma should ask why — it is not part of the usual pathway.
The hearing tests, and why they shape treatment
The audiogram does not make the diagnosis, but it is one of the three findings the plan rests on, and it deserves its own explanation:
- Pure tone audiometry — the test that measures, for each pitch, how loud a sound must be before each ear hears it. The result is plotted for both ears on one chart, and the difference between the two sides is what carries the information.
- Speech discrimination testing — a separate measure of how clearly words are understood at a comfortable volume. In this condition the clarity often deteriorates before the loudness, so a patient may hear sound and still fail to understand speech — and the discrimination score is the number the specialists watch most closely.
- Why the tests shape treatment — hearing that is still useful changes what is worth attempting: it is the difference between approaches that try to preserve the hearing and approaches that accept its loss. The audiogram is therefore taken before treatment and repeated after it, so that what was preserved is measured rather than assumed.
- What the tests do not do — they do not exclude a tumour on their own. A small proportion of tumours are found with a normal audiogram, which is why the decision to image is made on the pattern of symptoms rather than on the audiogram alone.
What else can look like this
The corner of the skull where these tumours sit hosts a short list of other causes, and the scan distinguishes between them:
- A meningioma of the same region — the other common tumour of the cerebellopontine angle. Its position, its shape and its pattern of enhancement differ from a schwannoma's, and an experienced reading usually distinguishes them without difficulty.
- Inner ear conditions — the commonest explanations for one-sided hearing loss and tinnitus by far: conditions of the cochlea and the balance organs, which produce symptoms identical to a small tumour's but leave the MRI normal. This is the usual outcome of the investigation, and it is a good one.
- Sudden loss from circulation or inflammation — a one-sided loss that arrives over hours is treated on its own timeline first; the MRI comes when the hearing fails to recover, and it is what finds the occasional tumour.
- Cysts and other rare lesions of the region, which the pattern of the scan separates from a schwannoma.
How the tumour is measured and recorded
Two systems are used to put the findings on record, and knowing them makes the reports readable:
- Size, in millimetres — the largest diameter, measured the same way on every scan so that successive studies can be compared. The measurement matters less as an absolute number than as a change over time.
- Grade, by the space the tumour occupies — commonly reported as Koos grades I to IV, running from a tumour contained within the canal (I) to one that compresses the brainstem (IV). The grade summarises position rather than behaviour, and it is the position that limits what treatment can safely do.
- Hearing class — the audiogram result converted into a category that records what the affected ear can still do. It sits alongside the size and the grade because it, too, belongs in the decision.
- Why consistency matters — measurements made on different scanners, or by different methods, drift by amounts larger than real growth. That is why follow-up is best kept at one centre, with the same protocol, and why the images rather than the report are what get compared.
When genetic assessment is offered
For most patients no genetic test is needed, and its absence from the plan is not a gap. Assessment is offered in specific situations:
- Tumours on both hearing nerves — the hallmark of neurofibromatosis type 2, and an indication for genetic assessment rather than an option.
- An unusually young patient — inherited forms announce themselves early, so a single tumour in a young adult is a reasonable reason to ask.
- A family history — a relative with neurofibromatosis type 2, or schwannomas in more than one relative.
- Other schwannomas or related tumours — multiple schwannomas elsewhere in the body raise the question of the rarer schwannomatosis conditions, which have their own assessment.
- What a diagnosis of NF2 changes — scheduled imaging of both sides rather than one, surveillance of the spine and other nerves, treatment decisions that weigh both sides together, and information that matters to relatives. It is a different pathway, which is why recognising it matters.
What the diagnosis should establish
By the end of the assessment, these are the questions that should have been answered, and asking for them by name is a reasonable check:
- How large the tumour is, and how far it extends — whether it is contained in the canal or has entered the space beside the brainstem.
- Whether it is growing, compared with any earlier scan — a comparison rather than a single measurement.
- What the hearing on the affected side is doing, in pure tone and in speech discrimination, on the record rather than in conversation.
- Whether the facial nerve and the nerve of facial sensation are involved, on examination now, before anything is done.
- What the options are — observation, radiation, surgery, or a combination — and what each would mean for the hearing and the face.
- What the follow-up would consist of, with intervals, for whichever option is chosen.
The reason to insist on all six is that the management of this tumour spans years, and each of these findings can alter what is done at a later stage. A plan that records them can be reviewed later on the basis of facts; a plan that records only a conclusion cannot.